Myeloma
-
Forward Look
First CAR-T Cell Therapy Approved for Multiple MyelomaCellular immunotherapies can offer periods when people do not require treatment.
by Christina Bennett
-
More Data on COVID-19 Vaccination and CancerStudies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Searching the Blood for Signs of Altered ImmunityThe immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
Multiple Myeloma: Choosing Your PathNew therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
-
Learning Medicare’s ABCDsMedicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
Policy Matters
Racial and Ethnic Disparities in Multiple Myeloma Clinical TrialsThe AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.
by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD
-
Forward Look
Learning How to Prevent Multiple MyelomaIrene Ghobrial on studying cancer precursors.
by Sue Rochman
-
Survivor Profile
A Long Road BackMultiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer.
by Lindsey Konkel
-
Vaccines: Looking Within for Cancer TreatmentResearchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
-
Treatment Is WaitingFor patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
